Skip to content

Author

A. Gasbarrini

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Risk factors for treatment failure of surgical site deep infections following spinal instrumentation: multicentre observational study (DeFEndO study)

Abstract Introduction: To describe the characteristics and outcome of patients diagnosed with deep surgical-site infections following spinal instrumentation (DSIIs) and to investigate risk factors for treatment failure including antimicrobial treatment duration as the main exposure. Materials and methods: An observatio...

R. Pascale, Mena Gallo, Nicolò Regge Gianas et al. · 0 citations
Open access Aug 2026

Chondrosarcoma of the mobile spine: impact of tumor status at referral and surgical strategy on oncological outcome.

BACKGROUND Chondrosarcoma (CHS) is a rare malignant bone tumor, mostly histologically low grade, demonstrating limited response to chemotherapy and conventional photon radiotherapy (RT). According to Enneking Staging System, tumor-free margin en bloc resection is the cornerstone of treatment. When arising in the spine...

I. Giannini, L. Mavilla, Benchao Shi et al. · 0 citations
Review Open access Aug 2026

SADA-08 FUSION SURGERY FOR PATIENTS WITH METASTATIC SPINE DISEASE: IS FUSION NECESSARY?

It is concluded that instrumented stabilization without formal fusion is a reasonable and potentially preferable approach for many patients with spinal metastases, especially true in cases of limited life expectancy and lower instability scores.

Andrew A. Hardigan, F. Landriel, F. Cofano et al. · 0 citations
Open access Aug 2026

SADA-14 WHEN COMPLICATIONS MATTER: THE IMPACT OF POSTOPERATIVE ADVERSE EVENTS ON SURVIVAL AND QUALITY OF LIFE IN METASTATIC SPINE DISEASE

Postoperative AE’s are extremely relevant to the care of patients with MSD and impact both HRQoL and survival and a multivariate analysis demonstrated that age, smoking status, ECOG performance, prior radiotherapy, presence of multiple metastases at other sites, and multiple spine metastases were significant risk facto...

Andrew A. Hardigan, G. B. Brodano, Christina Griffoni et al. · 0 citations
Open access Aug 2026

SADA-13 TOWARD CONSENSUS: DEFINING OPTIMAL SURGICAL OUTCOMES IN METASTATIC SPINE DISEASE

This is the first study defining a composite measure outcome in oncologic surgery for spinal metastases derived from an international group of surgeons and oncologists who treat patients for MSD and the OSCO-M will be useful for defining clinical success in patients undergoing treatment for MSD.

Andrew A. Hardigan, R. de la Garza Ramos, Michael H. Weber et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.